Literature DB >> 19616581

Complement and immune defense: from innate immunity to human diseases.

Peter F Zipfel1.   

Abstract

The human organism is constantly exposed to microbes and infectious agents and consequently has developed a complex and highly efficient immune defense which is aimed to recognize and eliminate such infectious agents. The response of the human host to infectious agents forms a double edged sword of immunity. The immune system has to keep a tight balance between attack on foreign surfaces and protection of host surfaces. In its proper function the immune response is aimed to recognize, attack and eliminate invading infectious agents and this response is beneficial for the host. However when the activated immune response like the complement system is not properly controlled and deregulated, effector compounds can attack and damage self-surfaces and this results in disease. In addition pathogens which cause infections and disease protect themselves from the damaging and harmful host immune weapon and use specific immune escape strategies. The complement system forms the first defense line of innate immunity and aids in the elimination of microbes and modified self-cells. Defective regulation of this cascade type system results in infections and in pathology. This can result in diseases, like severe renal diseases hemolytic uremic syndrome (HUS) and dense deposit disease (DDD), in age related macular degeneration a common form of blindness and also in other forms of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616581     DOI: 10.1016/j.imlet.2009.07.005

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  50 in total

1.  Plasminogen is a complement inhibitor.

Authors:  Diana Barthel; Susann Schindler; Peter F Zipfel
Journal:  J Biol Chem       Date:  2012-03-27       Impact factor: 5.157

2.  Inhibition of C5a receptor alleviates experimental CNS lupus.

Authors:  Alexander Jacob; Bradley Hack; Tao Bai; James R Brorson; Richard J Quigg; Jessy J Alexander
Journal:  J Neuroimmunol       Date:  2010-03-05       Impact factor: 3.478

3.  The Borrelia hermsii factor H binding protein FhbA is not required for infectivity in mice or for resistance to human complement in vitro.

Authors:  Lindy M Fine; Daniel P Miller; Katherine L Mallory; Brittney K Tegels; Christopher G Earnhart; Richard T Marconi
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

4.  Structural basis for sialic acid-mediated self-recognition by complement factor H.

Authors:  Bärbel S Blaum; Jonathan P Hannan; Andrew P Herbert; David Kavanagh; Dušan Uhrín; Thilo Stehle
Journal:  Nat Chem Biol       Date:  2014-11-24       Impact factor: 15.040

5.  Unilateral uterine ischemia/reperfusion-induced bilateral fetal loss and fetal growth restriction in a murine model require intact complement component 5.

Authors:  Xiao-Wu Qu; Tamas Jilling; Mark G Neerhof; Kehuan Luo; Emmet Hirsch; Larry G Thaete
Journal:  J Reprod Immunol       Date:  2012-06-09       Impact factor: 4.054

6.  Association assessment of copy number polymorphism and risk of age-related macular degeneration.

Authors:  Julie Sawitzke; Kate M Im; Brittany Kostiha; Michael Dean; Bert Gold
Journal:  Ophthalmology       Date:  2011-12       Impact factor: 12.079

7.  The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion.

Authors:  Shanshan Luo; Anna M Blom; Steffen Rupp; Uta-Christina Hipler; Bernhard Hube; Christine Skerka; Peter F Zipfel
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

8.  Microarray data integration for genome-wide analysis of human tissue-selective gene expression.

Authors:  Liangjiang Wang; Anand K Srivastava; Charles E Schwartz
Journal:  BMC Genomics       Date:  2010-11-02       Impact factor: 3.969

9.  Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.

Authors:  Corinna Siegel; Teresia Hallström; Christine Skerka; Hannes Eberhardt; Barbara Uzonyi; Tobias Beckhaus; Michael Karas; Reinhard Wallich; Brian Stevenson; Peter F Zipfel; Peter Kraiczy
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

10.  Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.

Authors:  Claudia Hammerschmidt; Arno Koenigs; Corinna Siegel; Teresia Hallström; Christine Skerka; Reinhard Wallich; Peter F Zipfel; Peter Kraiczy
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.